Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?

被引:279
作者
Curtis, T. M. [1 ]
Gardiner, T. A. [1 ]
Stitt, A. W. [1 ]
机构
[1] Queens Univ Belfast, Royal Victoria Hosp, Inst Clin Sci, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland
关键词
diabetes; diabetic retinopathy; blood flow; haemodynamics; hypoxia; ischaemia; ENDOTHELIAL GROWTH-FACTOR; RETINAL BLOOD-FLOW; ADVANCED GLYCATION; MACULAR EDEMA; SHEAR-STRESS; GLIAL-CELLS; PKC BETA; PDGF-B; ABNORMALITIES; DEATH;
D O I
10.1038/eye.2009.108
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Retinopathy is a major complication of diabetes mellitus and this condition remains a leading cause of blindness in the working population of developed countries. As diabetic retinopathy progresses a range of neuroglial and microvascular abnormalities develop although it remains unclear how these pathologies relate to each other and their net contribution to retinal damage. From a haemodynamic perspective, evidence suggests that there is an early reduction in retinal perfusion before the onset of diabetic retinopathy followed by a gradual increase in blood flow as the complication progresses. The functional reduction in retinal blood flow observed during early diabetic retinopathy may be additive or synergistic to proinflammatory changes, leucostasis and vasoocclusion and thus be intimately linked to the progressive ischaemic hypoxia and increased blood flow associated with later stages of the disease. In the current review a unifying framework is presented that explains how arteriolar dysfunction and haemodynamic changes may contribute to late stage microvascular pathology and vision loss in human diabetic retinopathy. Eye (2009) 23, 1496-1508; doi:10.1038/eye.2009.108; published online 15 May 2009
引用
收藏
页码:1496 / 1508
页数:13
相关论文
共 104 条
[91]  
Stearne MR, 1998, BMJ-BRIT MED J, V317, P703
[92]  
Stitt AW, 2005, PHARMACOL REP, V57, P156
[93]   HISTOLOGICAL AND ULTRASTRUCTURAL INVESTIGATION OF RETINAL MICROANEURYSM DEVELOPMENT IN DIABETIC-PATIENTS [J].
STITT, AW ;
GARDINER, TA ;
ARCHER, DB .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (04) :362-367
[94]   Advanced glycation end products and diabetic complications [J].
Stitt, AW ;
Jenkins, AJ ;
Cooper, ME .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (09) :1205-1223
[95]   DIABETIC-RETINOPATHY - QUANTITATIVE VARIATION IN CAPILLARY BASEMENT-MEMBRANE THICKENING IN ARTERIAL OR VENOUS ENVIRONMENTS [J].
STITT, AW ;
ANDERSON, HR ;
GARDINER, TA ;
ARCHER, DB .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1994, 78 (02) :133-137
[96]   A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy [J].
Sun, Wei ;
Oates, Peter J. ;
Coutcher, James B. ;
Gerhardinger, Chiara ;
Lorenzi, Mara .
DIABETES, 2006, 55 (10) :2757-2762
[97]  
THOUMINE O, 1995, LAB INVEST, V73, P565
[98]   PREVENTION OF HEMODYNAMIC AND VASCULAR ALBUMIN FILTRATION CHANGES IN DIABETIC RATS BY ALDOSE REDUCTASE INHIBITORS [J].
TILTON, RG ;
CHANG, K ;
PUGLIESE, G ;
EADES, DM ;
PROVINCE, MA ;
SHERMAN, WR ;
KILO, C ;
WILLIAMSON, JR .
DIABETES, 1989, 38 (10) :1258-1270
[99]   Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate [J].
Tolentino, MJ ;
Miller, JW ;
Gragoudas, ES ;
Jakobiec, FA ;
Flynn, E ;
Chatzistefanou, K ;
Ferrara, N ;
Adamis, AP .
OPHTHALMOLOGY, 1996, 103 (11) :1820-1828
[100]   Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes [J].
Tooke, JE .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2000, 14 (04) :197-200